For example, IL-10 suppresses I-κB kinase activity, blocks NF-κB activation [55, 56], reduces pro-inflammatory mediator production [55, 56], improves bacteria-induced lung inflammation [57], and protects animals against lethal endotoxemia [58] and sepsis [59]. Here, NFKB1 is linked to serum lipopolysaccharide activity.